Table 4. Multivariable Cox's proportional hazards regression model showing likelihood of first line treatment failure for the four treatment combinations at 12 months.
Variable | Total started first line HAART | Rx failure at 12 months | Hazard Ratio* | 95% CI | p-value | |
N = 1448 | n = 261 (%) | |||||
ART at | TDF+FTC+EFV | 82 | 16 (19.5%) | 0.98 | (0.39 to 2.45) | 0.963 |
start of 1st | TDF+3TC+EFV | 191 | 53 (27.8%) | 1.41 | (0.64 to 3.11) | 0.389 |
line | Truvada®+EFV | 326 | 56 (17.2%) | 0.94 | (0.48 to 1.85) | 0.855 |
HAART | Atripla® | 849 | 136 (16.0%) | 1 |
Adjusted for sex, age, ethnic group, baseline CD4 count, baseline viral load, stage of HIV at start of ART and year of starting first-line ART.